Anny Reyes1,2,3, Erik Kaestner1,3, Emily C Edmonds3,4, Anna Christina Macari1, Zhong Irene Wang5, Daniel L Drane6,7, Vineet Punia5, Robyn M Busch5,8, Bruce P Hermann9, Carrie R McDonald1,2,3. 1. Center for Multimodal Imaging and Genetics, University of California, San Diego, CA, USA. 2. San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA. 3. Department of Psychiatry, University of California, San Diego, CA, USA. 4. Veterans Affairs San Diego Healthcare System, San Diego, CA, USA. 5. Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. 6. Departments of Neurology and Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. 7. Department of Neurology, University of Washington, Seattle, WA, USA. 8. Department of Neurology, Cleveland Clinic, Cleveland, OH, USA. 9. Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Abstract
OBJECTIVE: To characterize the nature and prevalence of cognitive disorders in older adults with temporal lobe epilepsy (TLE) and compare their cognitive profiles to patients with amnestic mild cognitive impairment (ie, aMCI). METHODS: Seventy-one older patients with TLE, 77 aMCI, and 69 normal aging controls (NACs), all 55-80 years of age, completed neuropsychological measures of memory, language, executive function, and processing speed. An actuarial neuropsychological method designed to diagnose MCI was applied to individual patients to identify older adults with TLE who met diagnostic criteria for MCI (TLE-MCI). A linear classifier was performed to evaluate how well the diagnostic criteria differentiated patients with TLE-MCI from aMCI. In TLE, the contribution of epilepsy-related and vascular risk factors to cognitive impairment was evaluated using multiple regression. RESULTS: Forty-three TLE patients (60%) met criteria for TLE-MCI, demonstrating marked deficits in both memory and language. When patients were analyzed according to age at seizure onset, 63% of those with an early onset (<50 years) versus 56% of those with late onset (≥ 50 years) met criteria for TLE-MCI. A classification model between TLE-MCI and aMCI correctly classified 81.1% (90.6% specificity, 61.3% sensitivity) of the cohort based on neuropsychological scores. Whereas TLE-MCI showed greater deficits in language relative to aMCI, patients with aMCI showed greater rapid forgetting on memory measures. Both epilepsy-related risk factors and the presence of leukoaraiosis on MRI contributed to impairment profiles in TLE-MCI. SIGNIFICANCE: Cognitive impairment is a common comorbidity in epilepsy and it presents in a substantial number of older adults with TLE. Although the underlying etiologies are unknown in many patients, the TLE-MCI phenotype may be secondary to an accumulation of epilepsy and vascular risk factors, signal the onset of a neurodegenerative disease, or represent a combination of factors.
OBJECTIVE: To characterize the nature and prevalence of cognitive disorders in older adults with temporal lobe epilepsy (TLE) and compare their cognitive profiles to patients with amnestic mild cognitive impairment (ie, aMCI). METHODS: Seventy-one older patients with TLE, 77 aMCI, and 69 normal aging controls (NACs), all 55-80 years of age, completed neuropsychological measures of memory, language, executive function, and processing speed. An actuarial neuropsychological method designed to diagnose MCI was applied to individual patients to identify older adults with TLE who met diagnostic criteria for MCI (TLE-MCI). A linear classifier was performed to evaluate how well the diagnostic criteria differentiated patients with TLE-MCI from aMCI. In TLE, the contribution of epilepsy-related and vascular risk factors to cognitive impairment was evaluated using multiple regression. RESULTS: Forty-three TLE patients (60%) met criteria for TLE-MCI, demonstrating marked deficits in both memory and language. When patients were analyzed according to age at seizure onset, 63% of those with an early onset (<50 years) versus 56% of those with late onset (≥ 50 years) met criteria for TLE-MCI. A classification model between TLE-MCI and aMCI correctly classified 81.1% (90.6% specificity, 61.3% sensitivity) of the cohort based on neuropsychological scores. Whereas TLE-MCI showed greater deficits in language relative to aMCI, patients with aMCI showed greater rapid forgetting on memory measures. Both epilepsy-related risk factors and the presence of leukoaraiosis on MRI contributed to impairment profiles in TLE-MCI. SIGNIFICANCE: Cognitive impairment is a common comorbidity in epilepsy and it presents in a substantial number of older adults with TLE. Although the underlying etiologies are unknown in many patients, the TLE-MCI phenotype may be secondary to an accumulation of epilepsy and vascular risk factors, signal the onset of a neurodegenerative disease, or represent a combination of factors.
Authors: Matti Sillanpää; Anu Anttinen; Juha O Rinne; Juho Joutsa; Pirkko Sonninen; Matti Erkinjuntti; Bruce Hermann; Mira Karrasch; Maiju Saarinen; Petri Tiitta; Shlomo Shinnar Journal: Epilepsia Date: 2015-10-04 Impact factor: 5.864
Authors: Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi Journal: Alzheimers Dement Date: 2014-05-22 Impact factor: 21.566
Authors: L E M Breuer; E Grevers; P Boon; A Bernas; J W M Bergmans; R M H Besseling; D C W Klooster; A de Louw; R M C Mestrom; K Vonck; S Zinger; A P Aldenkamp Journal: Acta Neurol Scand Date: 2016-10-28 Impact factor: 3.209
Authors: Kathleen H Elverman; Zachary J Resch; Erin E Quasney; David S Sabsevitz; Jeffrey R Binder; Sara J Swanson Journal: Epilepsy Behav Date: 2019-05-09 Impact factor: 2.937
Authors: Michael Murphy; Paul D Smith; Martin Wood; Stephen Bowden; Terence J O'Brien; Kristian J Bulluss; Mark J Cook Journal: Epilepsia Date: 2010-02-19 Impact factor: 5.864
Authors: Marian Galovic; Victor Q H van Dooren; Tjardo S Postma; Sjoerd B Vos; Lorenzo Caciagli; Giuseppe Borzì; Juana Cueva Rosillo; Khue Anh Vuong; Jane de Tisi; Parashkev Nachev; John S Duncan; Matthias J Koepp Journal: JAMA Neurol Date: 2019-10-01 Impact factor: 18.302
Authors: Bruce Hermann; Lisa L Conant; Cole J Cook; Gyujoon Hwang; Camille Garcia-Ramos; Kevin Dabbs; Veena A Nair; Jedidiah Mathis; Charlene N Rivera Bonet; Linda Allen; Dace N Almane; Karina Arkush; Rasmus Birn; Edgar A DeYoe; Elizabeth Felton; Rama Maganti; Andrew Nencka; Manoj Raghavan; Umang Shah; Veronica N Sosa; Aaron F Struck; Candida Ustine; Anny Reyes; Erik Kaestner; Carrie McDonald; Vivek Prabhakaran; Jeffrey R Binder; Mary E Meyerand Journal: Neuroimage Clin Date: 2020-07-10 Impact factor: 4.881
Authors: Elena Nardi Cesarini; Claudio Babiloni; Nicola Salvadori; Lucia Farotti; Claudio Del Percio; Maria Teresa Pascarelli; Giuseppe Noce; Roberta Lizio; Fulvio Da Re; Valeria Isella; Lucio Tremolizzo; Michele Romoli; Jacopo C DiFrancesco; Lucilla Parnetti; Cinzia Costa Journal: Front Neurol Date: 2020-04-15 Impact factor: 4.003
Authors: Emily C Edmonds; Denis S Smirnov; Kelsey R Thomas; Lisa V Graves; Katherine J Bangen; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi Journal: Neurology Date: 2021-08-10 Impact factor: 11.800
Authors: Marc Norman; Sarah J Wilson; Sallie Baxendale; William Barr; Cady Block; Robyn M Busch; Alberto Fernandez; Erik Hessen; David W Loring; Carrie R McDonald; Bruce P Hermann Journal: Epilepsia Open Date: 2021-03-02